1,25-Dihydroxyvitamin D3 induces splenocyte apoptosis and enhances BALB/c mice sensitivity to toxoplasmosis

Journal of Steroid Biochemistry and Molecular Biology

Volumn 96, Issue 2, 2005, Pages 179-185

  Rajapakse, Rohan ^a   Mousli, Marc ^a   Pfaff, Alexander W ^a   Uring Lambert, Béatrice ^b   Marcellin, Luc ^b   Bronner, Christian ^a   Jeanblanc, Michaël ^a   Villard, Odile ^a   Letscher Bru, Valérie ^a   Klein, Jean Paul ^a   Candolfi, Ermanno ^a  

^a INSERM   (France)

^b HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

1,25 Dihydroxyvitamin D3; Apoptosis; Th 1 response; Toxoplasma gondii

Indexed keywords

CALCITRIOL; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; PROTEIN BCL 2; PROTEIN BCL XL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COUNT; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; MOUSE; NONHUMAN; SENSITIVITY ANALYSIS; SPLEEN CELL; SURVIVAL RATE; T LYMPHOCYTE; TH1 CELL; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; CALCITRIOL; CELL DIVISION; DISEASE SUSCEPTIBILITY; IMMUNITY, NATURAL; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, INBRED BALB C; SPLEEN; SURVIVAL RATE; TOXOPLASMOSIS;

TOXOPLASMA GONDII;

EID: 23344433586     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2005.03.002     Document Type: Article

References (31)

1. C.A. Redaelli, M. Wagner, Y.H. Tien, L. Mazzucchelli, P.F. Stahel, M.K. Schilling, and J.F. Dufour 1 alpha,25-Dihydroxycholecalciferol reduces rejection and improves survival in rat liver allografts Hepatology 34 2001 926
2. M. Simboli-Campbell, C.J. Narvaez, M. Tenniswood, and J. Welsh 1,25-Dihydroxy1,25-dihydroxyvitamin D3 induces morphological and biochemical markers of apoptosis in MCF-7 breast cancer cells J. Steroid Biochem. Mol. Biol. 58 1996 367
3. A. Brennan, D.R. Katz, J.D. Nunn, S. Barker, M. Hewison, L.J. Fraher, and J.L. O'Riordan Dendritic cells from human tissues express receptors for the immunoregulatory 1,25-dihydroxyvitamin D3 metabolite, dihydroxycholecalciferol Immunology 61 1987 457
4. D.M. Provvedini, C.D. Tsoukas, L.L. Deftos, and S.C. Manolagas 1,25-Dihydroxy1,25-dihydroxyvitamin D3 receptors in human leukocytes Science 16 1983 1181
5. E. van Etten, B. Decallonne, R. Bouillon, and C. Mathieu NOD bone marrow-derived dendritic cells are modulated by analogs of 1,25-dihydroxyvitamin D3 J. Steroid Biochem. Mol. Biol. 89-90 2004 457
6. T.P. Staeva-Vieira, and L.P. Freedman A1,25-dihydroxy1,25- dihydroxyvitamin D3 inhibits IFN-gamma and IL-4 levels during in vitro polarization of primary murine CD4+ T cells J. Immunol. 168 2002 1181
7. 3 Blood 76 1990 189
8. E. Denkers, and R.T. Gazzinelli Regulation and function of T-cell mediated immunity during Toxplasma gondii infection Clin. Microbiol. Rev. 11 1998 569
9. B.J. Luft, G. Kansas, E.G. Engelman, and J.S. Remington Functional and quantitative alteration in T lymphocyte sub populations in acute toxoplasmosis J. Infect. Dis. 150 1984 761
10. R.T. Gazzinelli, E.Y. Denkers, and A. Sher Host resistance to Toxoplasma gondii model for studying the selective induction of cell-mediated immunity by intracellular parasites Infect. Agents Dis. 2 1993 139
11. C. Mathieu, and L. Adorini The coming of age of 1,25-dihydroxy1,25- dihydroxyvitamin D3 analogs as immunomodulatory agents Trends Mol. Med. 8 2002 174
12. Y. Suzuki, Q. Yang, F.K. Conley, and J.S. Remington Antibody against Interleukin-6 reduces inflammation and number of cysts in brains of mice with toxoplasma encephalitis Infect. Immun. 62 1994 2773
13. F.K. Conley, and K.A. Jenkins Immunohistochemical study of the anatomic relationship of Toxoplasma antigens to the inflammatory response in the brains of mice chronically infected with Toxoplasma gondii Infect. Immun. 31 1981 1184
14. R. Hopfner, M. Mousli, J.M. Jeltsch, A. Voulgaris, Y. Lutz, C. Marin, J.P. Bellocq, P. Oudet, and C. Bronner ICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIalpha expression Cancer Res. 60 2000 121
15. + T cells to enhance the development of Th2 cells J. Immunol. 167 2001 4974
16. W.F. Rigby, R.J. Noelle, K. Krause, and M.W. Fanger The effects of 1,25-dihydroxy1,25-dihydroxyvitamin D3 on human T lymphocyte activation and proliferation: a cell cycle analysis J. Immunol. 135 1985 2279
17. R. Hopfner, M. Mousli, P. Oudet, and C. Bronner Overexpression of ICBP90, a novel CCAAT-binding protein, overcomes cell contact inhibition by forcing topoisomerase II alpha expression Anticancer Res. 22 2002 3165
18. A. Fujimori, Y. Matsuda, Y. Takemot, Y. Hashimoto, E. Kubo, R. Araki, R. Fukumura, K. Mita, K. Tatsumi, and M. Muto Cloning and mapping of Np95 gene which encodes a novel nuclear protein associated with cell proliferation Mamm. Genome 9 1998 1032
19. M. Mousli, R. Hopfner, A.Q. Abbady, D. Monte, M. Jeanblanc, P. Oudet, B. Louis, and C. Bronner ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells Br. J. Cancer 89 2003 120
20. M. Cantorana, A. Debra, C. Redaelli, R. Curtis, J.H.l. Winter, H. Sollinger, and H.F. Deluca 1,25-Dihydroxy1,25-dihydroxyvitamin D3 prolongs graft survival without compromising host to infection or bone mineral density Transplantation 66 1998 828
21. B.A. Mahon, A. Wittke, A.V. Weaver, and M.T. Cantorna The targets of vitamin D depends on the differentiation and activation status of CD4 positive T cells J. Cell. Biochem. 89 2003 922
22. K.W. Colston, S.K. Chander, A.G. Mackay, and R.C. Coombes Effects of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro Biochem. Pharmacol. 44 1992 693
23. D.M. Peehl, R.J. Skowronski, G.K. Leung, S.T. Wong, T.A. Stamey, and D. Feldman Anti-proliferative effects of 1,25-dihydroxy1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells Cancer Res. 54 1994 805
24. 3, inhibits azoxymethane-induced colonic tumorigenesis Cancer Res. 55 1995 3050
25. J.E. Osborne, and P.E. Hutchinson Vitamin D and systemic cancer: is this relevant to malignant melanoma? Br. J. Dermatol. 147 2002 197
26. R. Fife, G.J. Sledge, and C. Proctor Effects of 1,25-dihydroxyvitamin D3 on proliferation of cancer cells in vitro Cancer Lett. 120 1997 65
27. G. Diaz, C. Paraskeva, M. Thomas, L. Binderup, and A. Hague Apoptosis is induced by the active metabolite of 1,25-dihydroxyvitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy Cancer Res. 60 2000 2304
28. M. Guzey, S. Kitada, and J.C. Reed Apoptosis induction by 1α,25-dihydroxy1,25-dihydroxyvitamin D3 in prostate cancer Mol. Cancer Ther. 1 2002 667
29. C.J. Narvaez, and J. Welsh Role of mitochondria and caspases in vitamin D-mediated apoptosis of MCF-7 breast cancer cells J. Biol. Chem. 23 2001 9101
30. R.E. Molestina, T.M. Payne, I. Coppens, and A.P. Sinai Activation of NF-kappaB by Toxoplasma gondii correlates with increased expression of anti-apoptotic genes and localization of phosphorylated IkappaB to the parasitophorous vacuole membrane J Cell Sci. 116 2003 4359
31. H.J. Vial, M.J. Thuet, and J.R. Philippot Inhibition of the in vitro growth of Plasmodium falciparum by D vitamins and 1,25-dihydroxyvitamin D3 derivatives Mol. Biochem. Parasitol. 5 1982 189